2017•Jiefangjun yixue zazhiRequires access

Correlation of sole prenatal indication to fetal chromosomal karyotype abnormality

Ying Xu, Fenfen Guo, Li J. Yu, Xu Hui, Tingting Song, Jiao Zheng, Biliang Chen, Jianfang Zhang

Open publisher page 0 citations

Abstract

Objective  To analysis the clinical high risk factors for fetal chromosomal abnormalities. Methods  Amniocentesis, chromosomal karyotype analysis and other related methods were performed on 4829 pregnant women, who presented sole indication of prenatal diagnosis such as advanced age, high risk factors and fetal ultrasound abnormalities, for analyzing the correlations of those women to the incidence of fetal chromosomal abnormalities. Results  The detection rates of abnormal karyotype were 5.0% (57/1143), 1.7% (40/2367) and 4.3% (57/1319) in the older women group (age>35), abnormal maternal serological screening group and abnormal fetal ultrasound finding group, respectively. The detection rats of karyotype abnormality were 6.9% (23/333) in women with fetal congenital heart diseases, 8.5% (20/234) in those with abnormal amniotic fluid, 1.1% (1/89) in those with fetal ventriculomegaly, 1.1% (10/898) in those with fetal intracardiac hyperechogenicity, 5.9% (2/34) in those with fetal choroid cyst and 5.6% (1/18) in those with fetal renal pelvis broadening. Conclusion  The pregnant women with age>35, fetal sonographic structural anomalies or two or more soft marker abnormalities should be prenatally diagnosed and doing the genetic counseling combined with the family history. DOI: 10.11855/j.issn.0577-7402.2017.02.14

About this research paper

What this paper is about

Objective  To analysis the clinical high risk factors for fetal chromosomal abnormalities. Methods  Amniocentesis, chromosomal karyotype analysis and other related methods were performed on 4829 pregnant women, who presented sole indication of prenatal diagnosis such as advanced age, high risk factors and fetal ultrasound abnormalities, for analyzing the correlations of those women to the incidence of fetal chromosomal abnormalities. Results  The detection rates of abnormal karyotype were 5.0% (57/1143), 1.7% (40/2367) and 4.3% (57/1319) in the older women group (age>35), abnormal maternal serological screening group and abnormal fetal ultrasound finding group, respectively. The detection rats of karyotype abnormality were 6.9% (23/333) in women with fetal congenital heart diseases, 8.5% (20/234) in those with abnormal amniotic fluid, 1.1% (1/89) in those with fetal ventriculomegaly, 1.1% (10/898) in those with fetal intracardiac hyperechogenicity, 5.9% (2/34) in those with fetal choroid cyst and 5.6% (1/18) in those with fetal renal pelvis broadening. Conclusion  The pregnant women with age>35, fetal sonographic structural anomalies or two or more soft marker abnormalities should be prenatally diagnosed and doing the genetic counseling combined with the family history. DOI: 10.11855/j.issn.0577-7402.2017.02.14

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective  To analysis the clinical high risk factors for fetal chromosomal abnormalities. Methods  Amniocentesis, chromosomal karyotype analysis and other related methods were performed on 4829 pregnant women, who presented sole indication of prenatal diagnosis such as advanced age, high risk factors and fetal ultrasound abnormalities, for analyzing the correlations of those women to the incidence of fetal chromosomal abnormalities. Results  The detection rates of abnormal karyotype were 5.0% (57/1143), 1.7% (40/2367) and 4.3% (57/1319) in the older women group (age>35), abnormal maternal serological screening group and abnormal fetal ultrasound finding group, respectively. The detection rats of karyotype abnormality were 6.9% (23/333) in women with fetal congenital heart diseases, 8.5% (20/234) in those with abnormal amniotic fluid, 1.1% (1/89) in those with fetal ventriculomegaly, 1.1% (10/898) in those with fetal intracardiac hyperechogenicity, 5.9% (2/34) in those with fetal choroid cyst and 5.6% (1/18) in those with fetal renal pelvis broadening. Conclusion  The pregnant women with age>35, fetal sonographic structural anomalies or two or more soft marker abnormalities should be prenatally diagnosed and doing the genetic counseling combined with the family history. DOI: 10.11855/j.issn.0577-7402.2017.02.14

Key concepts: Fetus, Amniocentesis, Medicine, Obstetrics, Prenatal diagnosis, Karyotype, Abnormality, Genetic counseling

Related papers

Back to paper searchBrowse research topicsOriginal source
Correlation of sole prenatal indication to fetal chromosomal karyotype abnormality — Research Paper | ScholarLens